Dana-Farber Cancer Institute researchers will present key research studies at the 2025 Tandem Meetings, the premier ...

By Julie Parr Click here for updates on this story TEXARKANA, Texas (KTBS) — A Texarkana, Texas boy battling a rare genetic ...

A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.

Acute Myeloid Leukemia (AML) is a hematological malignancy characterized by the rapid, uncontrolled growth of immature myeloid cells, leading to bone marrow ...

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...

An estimated 12,000 children are born with thalassemia major, a severe form of the disease, in India each year, accounting ...

Minot State University, along with MSU Athletics and the Beaver football program have partnered with NMDP for a drive.

Vertex has entered a reimbursement agreement with NHS England enabling eligible SCD patients to access Casgevy in the public ...

The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...

Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...